Archive for February 2020

Medicine for domestic animals and livestock is a $34 billion market and growing. Two startups with local ties plan to capitalize on that with antibody and gene therapies for pets. Read More

Good morning, everyone. Here are the five things you need to know in Boston business news to get your day off to a smart start, and where I’ll be first thing this morning. Read More

In recent weeks, the agency has offered the company a potential path to resolving a long-running civil and criminal investigation, according to State Street. Read More

Despite having revenue from two commercial products, Alnylam Pharmaceuticals lost $886 million in 2019 — its biggest-ever net loss. But CEO John Maraganore believes the biotech could soon be one of the top five biopharma companies in the country. Read More

Still, Secretary of the Commonwealth Bill Galvin’s final rule came in for criticism from the U.S. Chamber of Commerce. Read More

Form D Friday is a Boston Business Journal feature highlighting regulatory filings from Boston-area companies raising capital for new projects or expanding their businesses. Read More

The Dr. Michael E. Haynes Arms building was approved in late 2016. Read More

The Massachusetts Convention Center Authority, in its push to sell the Hynes, is touting two new studies it commissioned, though those economic analyses come with limitations. Read More

Joshua Dyck, director of the Center for Public Opinion, says the Dunkin’ rating “pops off the page.” Read More

The Boston-based venture and growth stage investment firm co-founded by former acting MBTA general manager Brian Shortsleeve is planning to make minority and majority investments in eight to 10 companies. Read More